Tuesday, July 23, 2019

FDA issues Curaleaf CBD claims warning as calls mount to accelerate rulemaking

Federal drug authorities issued a warning Tuesday to one of the largest cannabis companies in the U.S. for how it is marketing and selling its CBD products. The U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Inc., a vertically integrated marijuana and hemp company based in Wakefield, Massachusetts. The FDA accuses […]

FDA issues Curaleaf CBD claims warning as calls mount to accelerate rulemaking is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



source https://hempgenixs.com/2019/07/23/fda-issues-curaleaf-cbd-claims-warning-as-calls-mount-to-accelerate-rulemaking/?utm_source=rss&utm_medium=rss&utm_campaign=fda-issues-curaleaf-cbd-claims-warning-as-calls-mount-to-accelerate-rulemaking

No comments:

Post a Comment